Leading Companies - Vaginal Pessary Industry

Jul, 2023 - by CMI

Leading Companies - Vaginal Pessary Industry

A pessary is a detachable device used to offer support in the area of a prolapse in the vagina (birth canal). A pessary is typically utilized when a woman with a prolapse wishes to avoid surgery or has medical issues that make surgery too risky.

The growth is primarily being caused by factors including the rising incidence of stress urinary incontinence and pelvic organ prolapse, as well as the rising number of older persons who are predisposed to pelvic organ prolapse.International demand for noninvasive treatment options for various conditions is also rising, which is anticipated to support the expansion of the global vaginal pessary market from 2022 to 2030. These elements, along with growing awareness and the accessibility of vaginal pessaries as a therapeutic option, are anticipated to fuel market expansion in the coming years.

The global Vaginal Pessary Market is anticipated to expand at a compound annual growth rate (CAGR) of 10.00% from 2022 to 2030.

Top Companies in the Vaginal Pessary Industry:

1. CooperSurgical, Inc.

CooperSurgical, Inc. was founded in 1990 and headquartered in Connecticut, United States. It operates in over 100 countries. In Jan 2023, the National Institute for Health and Care Excellence (NICE) has advised using a fetal pillow during birth if a baby's head becomes stuck in the pelvis, according to CooperSurgical, a world authority in fertility and women's health. By putting a strong emphasis on research and evidence in healthcare decision-making, NICE offers government recommendations and guidance to improve health and social care in the United Kingdom by the Department of Health and Social Care sponsors NICE, a non-departmental executive public entity.

2. MedGyn Products, Inc.

MedGyn Products, Inc. was founded in 1975 and headquartered in Illinois, USA. It operates in over 140 countries.

3. Thomas Medical, Inc.

Thomas Medical, Inc. was founded in 1984 and headquartered in Indiana, United States. It operates throughout the world.

4. Smiths Medical

Smiths Medical was founded in 1940 and headquartered in Minnesota, the US. It operates in over 50 countries.

5. Milex Products, Inc.

Milex Products, Inc. was founded in 1937 and headquartered in Illinois, United States. It operates in many countries.

6. Personal Medical Corp.

Personal Medical Corp was founded in 2003 and headquartered in Washington, United States. It operates in across 100 countries.

7. Panpac Medical Corp.

     Panpac Medical Corp. was founded in 1995 and headquartered in Taiwan. It operates in different countries.

8. Gyneas

Gyneas was founded in 1999 and headquartered in France. It operates in some countries.

9. Uromed Kurt Drews KG

Uromed Kurt Drews KG was founded in 1967 and headquartered in Schleswig-holstein, Germany. It operates in some countries.

10. Integra LifeSciences Corporation

Integra LifeSciences Corporation was founded in 1989 and headquartered in New Jersey, United States. It operates globally. Aneurysmal subarachnoid hemorrhage (aSAH) patients with hydrocephalus were managed with the Codman® Bactiseal® External Ventricular Drain (EVD) catheter set in July 2023, according to Integra LifeSciences Holdings Corporation a leading global provider of medical technology.

11. Boston Scientific Corporation

Boston Scientific Corporation was founded in 1979 and headquartered in Massachusetts, U.S. It operates in more than 100 countries. The FDA published a letter to healthcare providers in July 2023 stating that, based on its review of all available data and analyses; the excess risk of mortality associated with paclitaxel-coated devices to treat peripheral arterial disease (PAD) is no longer supported. The letter acknowledges the safety of paclitaxel-coated devices and provides an updated recommendation that removes the necessity that device manufacturers include explicit warning wording within device labeling.

*Definition: A soft, detachable object called a vaginal pessary is inserted into the vagina. It supports regions where pelvic organ prolapse (POP) has an impact.

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.